US Stock MarketDetailed Quotes

Keros Therapeutics (KROS)

Watchlist
  • 11.250
  • -0.050-0.44%
Trading Mar 9 11:12 ET
221.82MMarket Cap4.89P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics (KROS) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
Developing novel therapeutics14.26M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States3.55M100.00%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +2.73%
Sample Name
Sample Code
 +1.36%
Sample Name
Sample Code
 +0.77%
4
Palo Alto Networks
PANW
+0.67%
5
Vistra Energy
VST
+0.42%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +8.23%
Sample Name
Sample Code
 +7.59%
Sample Name
Sample Code
 +3.28%
4
JD.com
JD
+3.19%
5
Zai Lab
ZLAB
+3.15%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -